Varkey Anita B
John H. Stroger, Jr. Hospital of Cook County and Rush Medical College, Chicago, Illinois, USA.
Curr Opin Pulm Med. 2004 Mar;10(2):98-103. doi: 10.1097/00063198-200403000-00003.
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality throughout the world. This major public health threat is ranked twelfth as a worldwide burden of disease and is projected to rank fifth by the year 2020 as a cause of lost quantity and quality of life. The impact of this disease in women is significantly understudied but the evidence that does exist reveals potentially substantial gender differences in the susceptibility to, severity of, and response to management of COPD.
The best known risk factor for the development of COPD is tobacco smoking. While smoking rates in women have largely stabilized in developed countries, the rates are continuing to climb in developing countries. While it is not clear whether women are more susceptible to the toxic effects of cigarette smoke than men, it is known that the incidence and prevalence of COPD will continue to climb as more women smoke. Other known risk factors for the development of COPD include air pollution, infections, occupational exposures, and genetic factors. Air pollution, particularly fine particulate indoor air pollution from biomass fuels disproportionately affects women. Infections such as human immunodeficiency virus (HIV) and tuberculosis (TB) disproportionately affect vulnerable populations such as poor women and occupational exposures to various dusts and toxins are often gender specific. Genetic factors are still being explored but there seems a preponderance of women who are affected by early-onset and non-smoking related COPD. Women with COPD also seem to be underdiagnosed by physicians and may have different responses to medical treatment, smoking cessation interventions, and pulmonary rehabilitation programs.
Chronic obstructive pulmonary disease in women is an understudied subject but is gaining attention as a significant public health threat. In developed countries, efforts at preventing the initiation of tobacco smoking and targeting smoking cessation programs in women are needed. In developing countries, efforts to promote cleaner fuels, improved stoves, better home ventilation, reduce toxic dust and fume exposures, combat infectious diseases such as TB and HIV, and improve nutrition are all ways in which the lung health of women can be improved.
慢性阻塞性肺疾病(COPD)是全球发病和死亡的主要原因。这一重大公共卫生威胁在全球疾病负担中排名第十二,预计到2020年将成为导致生命数量和质量损失的第五大原因。该疾病对女性的影响研究明显不足,但现有证据显示,在COPD的易感性、严重程度及治疗反应方面可能存在显著的性别差异。
COPD发展最知名的危险因素是吸烟。在发达国家,女性吸烟率基本稳定,但在发展中国家仍在持续攀升。虽然尚不清楚女性是否比男性更容易受到香烟烟雾毒性影响,但随着吸烟女性增多,COPD的发病率和患病率将继续上升。COPD发展的其他已知危险因素包括空气污染、感染、职业暴露和遗传因素。空气污染,尤其是生物质燃料产生的室内细颗粒物空气污染对女性影响尤为严重。人类免疫缺陷病毒(HIV)和结核病(TB)等感染对贫困女性等弱势群体影响尤为严重,职业接触各种粉尘和毒素往往具有性别特异性。遗传因素仍在探索中,但似乎有更多女性受早发型和非吸烟相关COPD影响。患有COPD的女性似乎也未得到医生充分诊断,对药物治疗、戒烟干预和肺康复项目可能有不同反应。
女性慢性阻塞性肺疾病是一个研究不足的课题,但作为重大公共卫生威胁正日益受到关注。在发达国家,需要努力预防女性开始吸烟并针对女性开展戒烟项目。在发展中国家,推广清洁燃料、改进炉灶、改善家庭通风、减少有毒粉尘和烟雾暴露、防治TB和HIV等传染病以及改善营养等措施,都是改善女性肺部健康的途径。